sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
29-Apr-2016 17:42
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 476-500 out of 1222.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>

Public Release: 16-Jul-2015
PLOS Pathogens
Repeat infection with malaria parasites might make mosquitoes more dangerous
In malaria-endemic regions, humans are often infected repeatedly with the Plasmodium parasite. Little is known about possible co-infection and its consequences in the Anopheles mosquitoes that transmit the disease. A study published on July 16 in PLOS Pathogens reports that not only can individual mosquitoes accumulate infections from multiple blood feeds, but also that an existing malaria infection makes mosquitoes more susceptible to a second infection, and that infections reach higher densities when another strain is already present.

Contact: Laura Pollitt

Public Release: 16-Jul-2015
PLOS Pathogens
Breakthrough finding brings cure for flesh-eating skin disease 1 step closer
Scientists from the University of Surrey have made an important breakthrough in the fight against the flesh-eating tropical skin disease Buruli ulcer, by their discovery that the bacteria causes a blood clot in patients' skin, similar to those that cause deep vein thrombosis (DVT). The new findings mean that, like DVT, the clots may respond to anticoagulant medicines, heal more quickly and with fewer side effects than with antibiotics alone.

Contact: Peter La
University of Surrey

Public Release: 15-Jul-2015
Science Translational Medicine
Researchers have shown that a drug currently in testing shows potential to cure malaria
Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.

Contact: Debbie Bolles
UT Southwestern Medical Center

Public Release: 15-Jul-2015
UGA researchers develop breakthrough tools in fight against cryptosporidium
Researchers at the University of Georgia have developed new tools to study and genetically manipulate cryptosporidium, a microscopic parasite that causes the diarrheal disease cryptosporidiosis. Their discoveries, published in the journal Nature, will ultimately help researchers in academia and industry find new treatments and vaccines for cryptosporidium, which is a major cause of disease and death in children under two years old.
National Institutes of Health, US Centers for Disease Control and Prevention, UGA Research Foundation, Georgia Research Alliance

Contact: Boris Striepen
University of Georgia

Public Release: 15-Jul-2015
Molecular Psychiatry
High blood levels of growth factor correlate with smaller brain areas in patients with schizophrenia
High blood levels of a growth factor known to enable new blood vessel development and brain cell protection correlate with a smaller size of brain areas key to complex thought, emotion and behavior in patients with schizophrenia, researchers report in the journal Molecular Psychiatry.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 15-Jul-2015
Science Translational Medicine
University of Washington chemists help develop a novel drug to fight malaria
An international team of scientists -- led by researchers from the University of Washington and two other institutions -- has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive, and is suitable for clinical tests in humans.
National Institutes of Health

Contact: James Urton
University of Washington

Public Release: 14-Jul-2015
The Global Response to Ebola: Implications for Future Drug & Vaccine Development
Ebola vaccine trial begins in Senegal
A trial evaluating an Ebola vaccine has begun in Dakar, after initial work at Oxford's Jenner Institute. The announcement comes as a conference in Oxford discusses the global response to Ebola and implications for future drug and vaccine development. The first volunteers at Centre Hospitalier Universitaire le Dantec, Dakar, received an initial vaccination with a booster one week later. This short timescale could provide an option for a rapid vaccination programme in an outbreak.
European Union Horizon 2020 research and innovation programme, Wellcome Trust, UK Department of International Development

Contact: University of Oxford news office
University of Oxford

Public Release: 14-Jul-2015
More women, children now on lifesaving HIV treatment worldwide
Global scale-up of prevention of mother-to-child transmission of HIV services has yielded remarkable results. Between 2000 and 2014, the percentage of pregnant women living with HIV with access to ART rose to 73 percent and new HIV infections among children dropped by 58 percent--leading to 1.4 million averted pediatric HIV infections worldwide.

Contact: Johanna Harvey
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 13-Jul-2015
Journal of Bone and Mineral Research
Kidney, bladder stones do not increase postmenopausal women's risk of osteoporosis
Postmenopausal women with kidney or bladder stones are not at increased risk for osteoporosis, but they do have about a 15 percent increased risk of another painful stone, physician-scientists report.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 13-Jul-2015
Journal of Clinical Investigation
Researchers develop aerosolized vaccine that protects primates against Ebola
A collaborative team from the University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
National Institutes of Health

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 12-Jul-2015
Journal of Experimental Medicine
Scientists find molecular switch that creates long-term immunity
Melbourne researchers have identified a protein responsible for preserving the antibody-producing cells that lead to long-term immunity after infection or vaccination.
Leukaemia Foundation, Australian Research Council, National Health and Medical Research Council, Victorian Government Operational Infrastructure Scheme

Contact: Liz Williams
Walter and Eliza Hall Institute

Public Release: 10-Jul-2015
UTHealth's Barbara Murray honored by Rice University
Barbara Murray, M.D., director of the Division of Infectious Diseases at The University of Texas Health Science Center at Houston Medical School, was recognized by the Association of Rice Alumni at its Laureates Dinner May 16.

Contact: Robert Cahill
University of Texas Health Science Center at Houston

Public Release: 10-Jul-2015
Plastic and Reconstructive Surgery -- Global Open
Study shows variation in rates of secondary cleft lip and palate surgery
For children with cleft lip and palate, the chances of undergoing secondary surgery vary depending on the center where they're treated, reports a study in Plastic and Reconstructive Surgery -- Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 10-Jul-2015
Cell Metabolism
Ancestral diets determine vulnerability to type 2 diabetes
The middle classes from developing countries are more susceptible than western Caucasians to obesity, type 2 diabetes and cardiovascular disease in today's changing environment. New research published today in Cell Metabolism from the University of Sydney in Australia, the National Centre for Cell Science and the DYP Medical College in Pune, India, reveals this may be a result of the nutrition endured by their ancestors.

Contact: Sally Sitou
University of Sydney

Public Release: 9-Jul-2015
Doctors to get better access to digital data
With $1.3 million and a top-priority ranking from the National Institutes of Health, UA College of Engineering researchers are developing data compression software to make biomedical big data universally available.
National Institutes of Health

Contact: Daniel Stolte
University of Arizona

Public Release: 9-Jul-2015
Annals of Internal Medicine
Early HIV treatment improves survival in some patients with newly diagnosed TB
Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health. Those with strong immune systems, however, might benefit from waiting until after the end of the six-month TB treatment before initiating anti-HIV therapy, they found.
Swedish Council for Working Life and Social Research, NIH/National Institute for Allergy and Infectious Disease, AIDS Clinical Trial Group, Stellenbosch University Clinical Trial Unit, Medical Education Partnership Initiative and others

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 8-Jul-2015
The Lancet Infectious Diseases
Out-of-pocket health costs tied to antimicrobial resistance, Stanford study finds
The high out-of-pocket costs for antimicrobial drugs in many developing countries is leading to an increase in drug-resistant pathogens, according to a study by Stanford University researchers.
National Institutes of Health

Contact: Beth Duff-Brown
Stanford University Medical Center

Public Release: 8-Jul-2015
Cell Host & Microbe
Vanderbilt researchers develop antibodies to fight chikungunya virus
Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against the chikungunya virus in the current issue of Cell Host and Microbe.

Contact: Craig Boerner
Vanderbilt University Medical Center

Public Release: 7-Jul-2015
BMC Obesity
Higher vitamin D doses may be needed to restore healthy levels in overweight blacks
The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 7-Jul-2015
Nature Communications
The next anti-tuberculosis drug may already be in your local pharmacy
Testing thousands of approved drugs, EPFL scientists have identified an unlikely anti-tuberculosis drug: the over-the-counter antacid lansoprazole (Prevacid).
Swiss National Science Foundation, German Federal Ministry of Research and Education

Contact: Nik Papageorgiou
Ecole Polytechnique Fédérale de Lausanne

Public Release: 7-Jul-2015
Nature Communications
Study identifies new way to kill the malaria parasite
The discovery could pave the way to new treatments for the disease.
Medical Research Council, Wellcome Trust

Contact: MRC press office
University of Leicester

Public Release: 6-Jul-2015
Study explains how dengue virus adapts as it travels, increasing chances for outbreaks
A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.
The Singapore National Medical Research Council, Ministry of Health in Singapore, Institute of Molecular and Cell Biology, Agency of Science, Technology and Research in Singapore, National Institutes of Health

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 6-Jul-2015
New blood pressure guidelines may lead to under treatment of older adults
In 2014, the Joint National Committee released the eighth update to the blood pressure guidelines (JNC8P). These guidelines included a controversial decision to change the blood pressure goal that may lead to under treatment of adults 60 years of age or older. The JNC8P guidelines set a less stringent goal blood pressure of < 150/90 mmHg for individuals 60 years of age or older compared to the previous <140/90 mmHg goal.

Contact: Melissa Hanson
Minneapolis Heart Institute Foundation

Public Release: 6-Jul-2015
Safer, with more benefits: Parents' vaccine views shifting
Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents' views on vaccines became more favorable.

Contact: Beata Mostafavi
University of Michigan Health System

Public Release: 2-Jul-2015
PLOS Neglected Tropical Diseases
Rope-chewing technique an easy way to screen monkeys for disease
What a piece of rope and strawberry jam have to do with preventing the spread of zoonotic disease.
USAID Emerging Pandemic Threats Program, William J. Fulbright Fellowship

Contact: Tierra Smiley Evans
University of California - Davis

Showing releases 476-500 out of 1222.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>